Grethe Iren A. Borge

Dr. Grethe Iren A. Borge

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2018 in Comprehensive Reviews in Food Science and Food Safety
Verified
Journal Article
Open access
PDF file
AAA. Filipa Almeida
A. Filipa Almeida
GBGrethe Iren A. Borge
Grethe Iren A. Borge
MPMariusz K. Piskuła
Mariusz K. Piskuła
ATAdriana Tudose
Adriana Tudose
LTLiliana Tudoreanu
Liliana Tudoreanu
CSCláudia Nunes dos Santos
Cláudia Nunes dos Santos
After consumption of plant‐derived foods or beverages, dietary polyphenols such as quercetin are absorbed in the small intestine and metabolized by the body, or they are subject to catabolism by the gut microbiota followed by absorption of the resulting products by the colon. The resulting compounds are bioavailable, circulate in the blood as conjugates with glucuronide, methyl, or sulfate groups attached, and they are eventually excreted in the urine. In this review, the various conjugates from different intervention studies are summarized and discussed. In addition, the substantial variation between different individuals in the measured quercetin bioavailability parameters is assessed in detail by examining published human intervention studies where sources of quercetin have been consumed in the form of food, beverages, or supplements. It is apparent that most reported studies have examined quercetin and/or metabolites in urine and plasma from a relatively small number of volunteers. Despite this limitation, it is evident that there is less interindividual variation in metabolites which are derived from absorption in the small intestine compared to catabolites derived from the action of microbiota in the colon. There is also some evidence that a high absorber of intact quercetin conjugates could be a low absorber of microbiota‐catalyzed phenolics, and vice versa. From the studies reported so far, the reasons or causes of the interindividual differences are not clear, but, based on the known metabolic pathways, it is predicted that dietary history, genetic polymorphisms, and variations in gut microbiota metabolism would play significant roles. In conclusion, quercetin bioavailability is subject to substantial variation between individuals, and further work is required to establish if this contributes to interindividual differences in biological responses.

7 February 2013 in Journal of Internal Medicine
Verified
Journal Article
Open access
PDF file
Matti UusitupaMatti Uusitupa
Matti Uusitupa
KHK. Hermansen
K. Hermansen
MSM. J. Savolainen
M. J. Savolainen
USU. Schwab
U. Schwab
MKM. Kolehmainen
M. Kolehmainen
BÅB. Åkesson
B. Åkesson
Background: Different healthy food patterns may modify cardiometabolic risk. We investigated the effects of an isocaloric healthy Nordic diet on insulin sensitivity, lipid profile, blood pressure and inflammatory markers in people with metabolic syndrome.Methods: We conducted a randomized dietary study lasting for 18–24 weeks in individuals with features of metabolic syndrome (mean age 55 years, BMI 31.6 kg m−2, 67% women). Altogether 309 individuals were screened, 200 started the intervention after 4‐week run‐in period, and 96 (proportion of dropouts 7.9%) and 70 individuals (dropouts 27%) completed the study, in the Healthy diet and Control diet groups, respectively. Healthy diet included whole‐grain products, berries, fruits and vegetables, rapeseed oil, three fish meals per week and low‐fat dairy products. An average Nordic diet served as a Control diet. Compliance was monitored by repeated 4‐day food diaries and fatty acid composition of serum phospholipids.Results: Body weight remained stable, and no significant changes were observed in insulin sensitivity or blood pressure. Significant changes between the groups were found in non‐HDL cholesterol (−0.18, mmol L−1 95% CI −0.35; −0.01, P = 0.04), LDL to HDL cholesterol (−0.15, −0.28; −0.00, P = 0.046) and apolipoprotein B to apolipoprotein A1 ratios (−0.04, −0.07; −0.00, P = 0.025) favouring the Healthy diet. IL‐1 Ra increased during the Control diet (difference −84, −133; −37 ng L−1, P = 0.00053). Intakes of saturated fats (E%, beta estimate 4.28, 0.02; 8.53, P = 0.049) and magnesium (mg, −0.23, −0.41; −0.05, P = 0.012) were associated with IL‐1 Ra.Conclusions: Healthy Nordic diet improved lipid profile and had a beneficial effect on low‐grade inflammation.


2 February 2010 in European Journal of Nutrition
Verified
Journal Article
Closed access
PDF file
AKAnette Karlsen
Anette Karlsen
IPIngvild Paur
Ingvild Paur
SBSiv K. Bøhn
Siv K. Bøhn
ASAmrit K. Sakhi
Amrit K. Sakhi
GBGrethe Iren A. Borge
Grethe Iren A. Borge
RBRune Blomhoff
Rune Blomhoff

1 August 2008 in Food Chemistry
Verified
Journal Article
Closed access
JVJon Volden
Jon Volden
GBGrethe Iren A. Borge
Grethe Iren A. Borge
GBGunnar B. Bengtsson
Gunnar B. Bengtsson
MHMagnor Hansen
Magnor Hansen
ITIngrid E. Thygesen
Ingrid E. Thygesen
TWTrude Wicklund
Trude Wicklund

1 January 2009 in LWT
Verified
Journal Article
Closed access
JVJon Volden
Jon Volden
GBGrethe Iren A. Borge
Grethe Iren A. Borge
MHMagnor Hansen
Magnor Hansen
TWTrude Wicklund
Trude Wicklund
GBGunnar B. Bengtsson
Gunnar B. Bengtsson